biological therapy podcasts

Unsuccessful Regulatory Filings for Biosimilar Approval: A Comprehensive Review

Play Episode Listen Later Aug 15, 2023

A recent paper in Expert Opinion on Biological Therapy studies failed fillings for biosimilar drugs. Over the past three decades, biotherapeutics have revolutionized healthcare by providing effective treatments for complex diseases… The post Unsuccessful Regulatory Filings for Biosimilar Approval: A Comprehensive Review appeared first on DrugPatentWatch - Make Better Decisions.

approval comprehensive regulatory unsuccessful expert opinions biosimilar biological therapy

Chemo & Biological Therapy: Corissa makes it easy!

TheOncoPT Podcast

Play Episode Listen Later Apr 6, 2023 50:39

It can be easy to get lost in all the different cancer treatments & side effects."What does what again?"Good thing Corissa Decker, BSN, RN, BMTCN is back to teach us about common side effects, mechanisms, & other things to know about chemotherapy & biological therapy, but don't worry: she makes it easy to follow & understand, so you'll walk away with exactly what you need to know!Listen now!Writing your oncology specialty exam case report is a huge undertaking. And it's easy to make silly mistakes that can derail your entire writing process.Make sure you're not forgetting these 5 crucial things when writing your case report!Grab your FREE checklist now! Case reports can seem daunting & overwhelming. And how are you supposed to fit writing into your already busy schedule?You need the Case Report Writing Workshop!Case Report Writing Workshop is my proven method to transform your blank screen into a complete first draft of your case report, without pulling out your hair in the process. Enroll today at TheOncoPT.com/casereport! Case Report Writing Workshop is my proven method to transform your blank screen into a complete first draft of your case report, without pulling out your hair in the process. Best of all, it's approved for 8 PT CEU hours! Enroll today at TheOncoPT.com/casereport.Follow TheOncoPT on Instagram.Follow TheOncoPT on TikTok.Follow TheOncoPT on Twitter.

tiktok writing rn enroll bsn chemo biological therapy bmtcn

E67: Real-life Experience of Biological Therapy for Hidradenitis Suppurativa

The Dermatology Podcast

Play Episode Listen Later Aug 9, 2022 25:01

In this episode of the EADV podcast, our host Dr Sarah Walsh meets Professor Wayne Gulliver to discuss his experience in the real world of using adalimumab in the management of hidradenitis suppurativa. They discuss practical application of scoring systems, and how early attainment of disease control might alter long-term outcomes. His paper, the SOLACE study, describes clinical experience in greater detail here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.17598

real life solace life experiences hidradenitis suppurativa sarah walsh biological therapy

David Parkinson, ESSA Pharma - Part of the Name Tag Series

Solebury Trout Talks

Play Episode Listen Later Nov 20, 2020 32:02

Dr. Parkinson has served as President and Chief Executive Officer of ESSA Pharma Inc. since January 2016, and as a Director of the company since June 2015. Prior to joining ESSA he had been a Venture Partner at New Enterprise Associates, Inc. From 2007 until 2012, Dr. Parkinson served as President and CEO of Nodality, Inc., a biotechnology company focused on the biological characterization of signaling pathways in patients with malignancy. Until October 2007 he was SVP, Oncology Research and Development at Biogen Idec, where he oversaw all oncology discovery research efforts and the development of the oncology pipeline. Previously he had served as VP, Oncology Development, at Amgen and VP, Global Clinical Oncology Development, at Novartis. In those roles he oversaw the successful clinical development of a series of cancer therapeutics, including Gleevec, Zometa, Femara, and Vectibix. Dr. Parkinson worked at the National Cancer Institute from 1990 to 1997, serving as Chief of the Investigational Drug Branch and then as Acting Associate Director of the Cancer Therapy Evaluation Program (CTEP). He is a past Chairman of the Food & Drug Administration (FDA) Biologics Advisory Committee, a past member of the FDA Science Board, and is a recipient of the FDA’s Cody Medal. He is a past editor of the Journal of Immunotherapy and past president of the Society of Biological Therapy. He has served on the National Cancer Policy Forum of the Institute of Medicine and is a past co-chair of the Cancer Steering Committee of the NIH Foundation Biomarkers Consortium. A past Board Director of the Ontario Institute for Cancer Research, he currently serves as a Board Director for the Multiple Myeloma Research Foundation. He served as Chairperson of the American Association of Cancer Research (AACR) Finance and Audit Committee for 15 years and is a previous elected Board Director of AACR. Dr. Parkinson was a Director of Facet Biotech, Inc., until the acquisition by Abbott Pharmaceuticals, and was a Director of Ambit Biosciences until the acquisition by Daiichi Sankyo. He was also previously a Director at Threshold Pharmaceuticals and Cerulean Pharmaceuticals. He currently serves as Director on the Boards of CTI Biopharma, Inc (CTIC), 3SBio Inc (1530.HK) and is a Co-Founder and Director of Refuge Biotech, Inc. He has held academic positions both at Tufts and at the University of Texas MD Anderson Cancer Center, and has authored over 100 peer-reviewed publications.

ceo director university president society co founders food development medicine chief institute journal fda chief executive officer parkinson boards svp american association pharma chairperson cancer research novartis hk board directors immunotherapy tufts national cancer institute amgen venture partner audit committee texas md anderson cancer center ontario institute aacr daiichi sankyo new enterprise associates oncology research multiple myeloma research foundation gleevec biogen idec biological therapy

Ep. 64 - Chemo & Biological Therapy: Corissa makes it easy!

TheOncoPT Podcast

Play Episode Listen Later Feb 26, 2020 48:18

It can be easy to get lost in all the different cancer treatments & side effects. "What does what again?" Good thing Corissa Decker, BSN, RN, BMTCN is back to teach us about common side effects, mechanisms, & other things to know about chemotherapy & biological therapy, but don't worry: she makes it easy to follow & understand, so you'll walk away with exactly what you need to know!

therapy cancer exercise therapists activity rehab rn rehabilitation oncology dpt bsn chemotherapy physiotherapy physiotherapists chemo immunotherapy lymphedema biological therapy